Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025;26(7):957-971.
doi: 10.2174/0113892010291326240214095327.

The Hepatoprotective Effects of Ginsenoside from Ginseng: A Review of Molecular Mechanisms and Therapeutic Potentials

Affiliations
Review

The Hepatoprotective Effects of Ginsenoside from Ginseng: A Review of Molecular Mechanisms and Therapeutic Potentials

Seyed Reza Taha et al. Curr Pharm Biotechnol. 2025.

Abstract

Treatment of hepatic diseases presents a significant challenge due to their diverse nature. Ginsenosides, bioactive compounds derived from the root of Panax ginseng and widely used in traditional Chinese medicine, offer multifaceted protection to various organs in the body. Their versatile effects, including antioxidant, anti-inflammatory, anti-apoptotic and more, make them a promising approach for addressing hepatic disorders. This review explores the intricate molecular mechanisms and properties of ginsenosides in the prevention and treatment of liver ailments, from mild conditions to severe damage and liver fibrosis. Given the increasing prevalence of hepatic disorders, this article sheds light on the significant pharmaceutical potential of ginsenosides in the realm of hepatic disease management.

Keywords: Ginsenoside; alcoholic liver disease; drug-induced liver injury; hepatic ischemia-reperfusion injury; liver fibrosis.; non-alcoholic fatty liver disease; viral hepatitis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Reinke H.; Asher G.; Crosstalk between metabolism and circadian clocks. Nat Rev Mol Cell Biol 2019,20(4),227-241 - DOI - PubMed
    1. Asrani S.K.; Devarbhavi H.; Eaton J.; Kamath P.S.; Burden of liver diseases in the world. J Hepatol 2019,70(1),151-171 - DOI - PubMed
    1. Ibrahim I.M.; Althagafy H.S.; Abd-alhameed E.K.; Al-Thubiani W.S.; Hassanein E.H.M.; Promising hepatoprotective effects of lycopene in different liver diseases. Life Sci 2022,310,121131 - DOI - PubMed
    1. Li S.; Tan H.Y.; Wang N.; Zhang Z.J.; Lao L.; Wong C.W.; Feng Y.; The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci 2015,16(11),26087-26124 - DOI - PubMed
    1. Friedman S.L.; Liver fibrosis – from bench to bedside. J Hepatol 2003,38(Suppl. 1),38-53 - DOI - PubMed

LinkOut - more resources